MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 25, 2005; DOI: 10.1124/mol.105.014134


0026-895X/05/6803-711-719$20.00
Mol Pharmacol 68:711-719, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014134v1
68/3/711    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sodhi, M. S. K.
Right arrow Articles by Sanders-Bush, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sodhi, M. S. K.
Right arrow Articles by Sanders-Bush, E.

A Rapid New Assay to Detect RNA Editing Reveals Antipsychotic-Induced Changes in Serotonin-2C Transcripts

Monsheel S. K. Sodhi, David C. Airey, Warren Lambert, Philip W. J. Burnet, Paul J. Harrison, and Elaine Sanders-Bush

Departments of Pharmacology and Psychiatry, Vanderbilt University, Nashville, Tennessee (M.S.K.S., D.C.A., E.S.-B.); Vanderbilt Kennedy Center for Research on Human Development, Nashville, Tennessee (W.L., E.S.-B.); and Department of Psychiatry, University of Oxford, Oxford, United Kingdom (P.W.J.B., P.J.H.)

We report the development of a new assay as an alternative to direct DNA sequencing to measure RNA-edited variation in tissue. The new assay has been validated and is accurate, cheaper, more rapid, and less labor-intensive than DNA sequencing. We also outline the statistical modeling required for analyses of the hierarchical, clustered RNA-editing data generated in these studies. Using the new technique, we analyzed the effects of long-term antipsychotic medication on serotonin-2C receptor (5-HT2CR) RNA editing in rat brain. Our hypothesis that a drug with high affinity for 5-HT2CR, such as clozapine, would alter its RNA-editing profile was not confirmed. Whereas haloperidol, a typical antipsychotic drug that is primarily a dopamine receptor antagonist, reduced 5-HT2C VNV isoform frequency and the level of RNA editing at the D site, risperidone and not the prototype atypical antipsychotic drug clozapine increased the frequency of 5-HT2C VNV and D-site editing. Our data emphasize that caution is required in the interpretation of RNA-editing data in studies of psychiatric disorders, because these studies usually include subjects who received long-term exposure to medication. This newly established method will facilitate high-throughput investigations of RNA editing in disease pathology and in the pharmacological activity of drugs.


Received April 26, 2005; accepted May 24, 2005

Address correspondence to: Dr. Monsheel Sodhi, Departments of Psychiatry and Pharmacology, Vanderbilt University, 8148 Medical Research Building III, 465 21st Avenue South, Nashville, TN 37212. E-mail: monsheel.sodhi{at}vanderbilt.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Singh, R. A. Kesterson, M. M. Jacobs, J. M. Joers, J. C. Gore, and R. B. Emeson
Hyperphagia-mediated Obesity in Transgenic Mice Misexpressing the RNA-editing Enzyme ADAR2
J. Biol. Chem., August 3, 2007; 282(31): 22448 - 22459.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
K. Gardiner and Y. Du
A-to-I editing of the 5HT2C receptor and behaviour
Brief Funct Genomic Proteomic, March 1, 2006; 5(1): 37 - 42.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics